MyxoBiomedical
PrivateTotal Funding Raised
$1M
Company Overview
MyxoBiomedical is a biotechnology company that develops resistance-breaking macrolide antibiotics based on the myxobacterial natural product scaffold chlorotonil for the treatment of MRSA and VRE infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MyxoBiomedical Comparables
Compare MyxoBiomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| smartbax GmbH | 88% | |
| Macrolide Pharmaceuticals | 87% | |
| APY Therapeutics | 85% | |
MyxoBiomedical Funding Rounds
Historical fundraising activity
MyxoBiomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
MyxoBiomedical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MyxoBiomedical's valuation, stock price, and market status.